Cholesterol Management Product description The present Competitive Intelligence Report provides a competitor evaluation in the field of molecules used to treat dyslipidemia as of May 2007. The report includes a compilation of current therapies of dyslipidemia and hypercholesterolemia including sales figures of 2006 and new projects in research and development. The competitor evaluation of Molecules to treat dyslipidemia by reducing LDL cholesterol or raise HDL cholesterol includes parts of our Competitor Analysis Series which previously have been published in R&D Pipeline News, vol.3, 2007. Competitor projects are listed in a tabular format providing Information on: - Drug Codes,
- Target / Mechanism of Action,
- Class of Compound,
- Company,
- Product Category
- Indication,
- R&D Stage and
- additional comments with a hyperlink leading to the source of information.
Index - Competitor Analysis
- Cholesterol Management Market: Sales 2006
- Statins
- Cholesterol Absorption Inhibitors
- Fibrates / PPAR? Agonists
- Nicotinic acid / Niacin
- Bile Acid Sequestrants
- Microsomal triglyceride transfer protein inhibitors (MTP Inhibitors)
- Cholesterol Absorption Inhibitors (CAI)
- Cholesterol Ester Transfer Protein Inhibitors (CETP Inhibitors)
- Reverse Cholesterol Transport Activators (RCTA) & Apoliporotein A-I Agonists
- Thyroid Hormone Receptor beta Agonists
- Liver X Receptor Modulator
- PPAR alpha Agonists / Fibrates
- Dual PPAR alpha / gamma Agonists
- PPAR delta Agonists
- Niacin type developments
- Various (incl. ApoB, oxLDL)
- About La Merie Business Intelligence
About Competitor Analysis Series The Competitor Analysis Series delivers NO-FRILLS , but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced. Competitor analysis reports can be purchased as individual products or obtained by subscribing to R&D Pipeline News. R&D Pipeline News is published weekly 50-times a year and each issue contains at least two competitor evaluations. Individual products from the Competitor Analysis Series and R&D Pipeline News are independently elaborated by analysts of La Merie Business Intelligence and distributed by PipelineReview.com.
|
